Download This PaperCompetitive Advantage in New Patent Regime: A Study of the Indian Pharmaceutical Industry
Indore Management Journal, Special Issue 2012
18 Pages Posted: 9 Apr 2012 Last revised: 25 Feb 2019
Date Written: April 9, 2012
Abstract
The introduction of product patent regime in 2005 forced the firms in the Indian Pharmaceutical Industry (IPI) to rethink their sources of competitive advantage. The absence of an appropriate funding mechanism through the Indian government and the acquisition of Indian pharmaceutical firms by MNCs have added to the woes. This study mainly focuses on how firms in the IPI would respond in such a scenario.
Keywords: Indian Pharmaceutical Industry, productpatent regime, competitive advantage, resource-based view (RBV), government support, strategic options, key capabilities
Suggested Citation: Suggested Citation
Do you have a job opening that you would like to promote on SSRN?
Recommended Papers
-
Intellectual Property Rights and North-South Trade
By Judith C. Chin and Gene M. Grossman
-
International Protection of Intellectual Property
By Gene M. Grossman and Edwin L.-c. Lai
-
International Protection of Intellectual Property
By Gene M. Grossman and Edwin L.-c. Lai
-
Reaping What You Sow: An Empirical Analysis of International Patent Harmonization
-
International Protection of Intellectual Property
By Gene M. Grossman and Edwin L.-c. Lai
-
Patents, Appropriate Technology, and North-South Trade
By Ishac Diwan and Dani Rodrik
-
The North's Intellectual Property Rights Standard for the South?
By Edwin L.-c. Lai and Larry D. Qiu